✦ LIBER ✦

Are elevated levels of the tumour marker CA19-9 of any clinical significance? — An evaluation

✍ Scribed by R. McLaughlin; D. O’Hanlon; M. Kerin; P. Kenny; H. Grimes; H. F. Given

Publisher: Springer-Verlag
Year: 1999
Tongue: English
Weight: 295 KB
Volume: 168
Category: Article
ISSN: 1863-4362
DOI: 10.1007/bf02946481

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of five glycoprotein tumour m

Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma

✍ Kjell Grankvist; Börje Ljungberg; Torgny Rasmuson 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 53 KB 👁 1 views

Increased levels of glycoprotein tumour markers have been observed in sera of patients with renal-cell carcinoma. Five different glycoprotein markers [carcinoembryonic antigen (CEA), CA-50, CA-19-9, CA-125 and CA-15-3] were assessed in 154 consecutive patients with renal-cell carcinoma before initia

Initial clinical evaluation of an immuno

Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the nci serum bank

✍ Roy E. Ritts Jr.; Bert C. del Villano; V. L. W. Go; Ronald B. Herberman; Thomas 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 712 KB

## Abstract More than 1,600 coded sera obtained from blood donors and the NCI/Mayo Clinic Serum Bank were analyzed with an improved immunoradiometric assay for the carbohydrate antigenic determinant, CA 19‐9. Results indicated that CA 19‐9 is elevated in a large fraction of sera (67%) from patients